Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake
Shaomin Li, Soyon Hong, Nina E. Shepardson, et al.
Neuron (2009) Vol. 62, Iss. 6, pp. 788-801
Open Access | Times Cited: 887

Showing 1-25 of 887 citing articles:

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Pierre Paoletti, Camilla Bellone, Qiang Zhou
Nature reviews. Neuroscience (2013) Vol. 14, Iss. 6, pp. 383-400
Closed Access | Times Cited: 2221
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova, Eric Karran, Bart De Strooper
Nature Neuroscience (2012) Vol. 15, Iss. 3, pp. 349-357
Closed Access | Times Cited: 1803
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Jorge J. Palop, Lennart Mucke
Nature Neuroscience (2010) Vol. 13, Iss. 7, pp. 812-818
Open Access | Times Cited: 1495
Dendritic spine pathology in neuropsychiatric disorders
Peter Penzes, Michael E. Cahill, Kelly A. Jones, et al.
Nature Neuroscience (2011) Vol. 14, Iss. 3, pp. 285-293
Open Access | Times Cited: 1439
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
D. Allan Butterfield, Barry Halliwell
Nature reviews. Neuroscience (2019) Vol. 20, Iss. 3, pp. 148-160
Open Access | Times Cited: 1412
The Amyloid-β Pathway in Alzheimer’s Disease
Harald Hampel, John Hardy, Kaj Blennow, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 5481-5503
Open Access | Times Cited: 1041
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Tara L. Spires‐Jones, Bradley T. Hyman
Neuron (2014) Vol. 82, Iss. 4, pp. 756-771
Open Access | Times Cited: 1030
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Lennart Mucke, Dennis J. Selkoe
Cold Spring Harbor Perspectives in Medicine (2012) Vol. 2, Iss. 7, pp. a006338-a006338
Open Access | Times Cited: 933
Long-term depression in the CNS
Graham L. Collingridge, Stéphane Peineau, John G. Howland, et al.
Nature reviews. Neuroscience (2010) Vol. 11, Iss. 7, pp. 459-473
Closed Access | Times Cited: 860
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin, Nina E. Shepardson, Ting Yang, et al.
Proceedings of the National Academy of Sciences (2011) Vol. 108, Iss. 14, pp. 5819-5824
Open Access | Times Cited: 846
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Ian W. Hamley
Chemical Reviews (2012) Vol. 112, Iss. 10, pp. 5147-5192
Open Access | Times Cited: 838
Network abnormalities and interneuron dysfunction in Alzheimer disease
Jorge J. Palop, Lennart Mucke
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 12, pp. 777-792
Open Access | Times Cited: 819
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Jaime N. Guzmán, Javier Sánchez-Padilla, David L. Wokosin, et al.
Nature (2010) Vol. 468, Iss. 7324, pp. 696-700
Open Access | Times Cited: 805
Protein aggregation diseases: pathogenicity and therapeutic perspectives
Adriano Aguzzi, Tracy O’Connor
Nature Reviews Drug Discovery (2010) Vol. 9, Iss. 3, pp. 237-248
Closed Access | Times Cited: 714
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Tiantian Guo, Denghong Zhang, Yuzhe Zeng, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 703
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Leslie Crews, Eliezer Masliah
Human Molecular Genetics (2010) Vol. 19, Iss. R1, pp. R12-R20
Open Access | Times Cited: 687
Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease
Marc Aurel Busche, Xiaowei Chen, Horst A. Henning, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 22, pp. 8740-8745
Open Access | Times Cited: 617
Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson, Brian Halabisky, Jong W. Yoo, et al.
Journal of Neuroscience (2011) Vol. 31, Iss. 2, pp. 700-711
Open Access | Times Cited: 611
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model
Pascal E. Sanchez, Lei Zhu, Laure Verret, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 42
Open Access | Times Cited: 596
Astrocyte function from information processing to cognition and cognitive impairment
Mirko Santello, Nicolas Toni, Andrea Volterra
Nature Neuroscience (2019) Vol. 22, Iss. 2, pp. 154-166
Open Access | Times Cited: 594
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease
Christian Lüscher, Kimberly M. Huber
Neuron (2010) Vol. 65, Iss. 4, pp. 445-459
Open Access | Times Cited: 592
Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
Shaomin Li, Ming Jin, Thomas Koeglsperger, et al.
Journal of Neuroscience (2011) Vol. 31, Iss. 18, pp. 6627-6638
Open Access | Times Cited: 586
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Maria Talantova, Sara Sanz‐Blasco, Xiaofei Zhang, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 27
Open Access | Times Cited: 529
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
Marcello D’Amelio, Virve Cavallucci, Silvia Middei, et al.
Nature Neuroscience (2010) Vol. 14, Iss. 1, pp. 69-76
Open Access | Times Cited: 528
Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease
Dimitrios Kapogiannis, Mark P. Mattson
The Lancet Neurology (2010) Vol. 10, Iss. 2, pp. 187-198
Open Access | Times Cited: 526
Page 1 - Next Page

Scroll to top